{"id":349783,"date":"2026-11-17T10:59:37","date_gmt":"2026-11-17T05:29:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=349783"},"modified":"2026-11-17T10:59:37","modified_gmt":"2026-11-17T05:29:37","slug":"ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/","title":{"rendered":"TTK Healthcare Share Price Surges Up to 20% on 17 November 2026 as the Board Meets on 20 November to Consider a Bonus Issue of Preference Shares, With Rs 256 Crore of Brand Sale Cash and a Low Price to Earnings in Focus"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>TTK Healthcare Rs 1,054.95 (+14.44%, 10:56 AM, 17 Nov). Day high Rs 1,110.90 (+20%). Board meets 20 Nov. Brand sale cash Rs 256 crore. Q2 profit Rs 222.97 crore. P\/E 4.7.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">TTK Healthcare shares rose as much as 20% to Rs 1,110.90 on 17 November, and traded near Rs 1,055 at 10:56 AM, up about 14%, after the company said its board will meet on 20 November to consider a scheme to give equity shareholders bonus non-convertible redeemable preference shares. The filing does not give the ratio, tenure, payout or reason, so those details are unknown until the board decides. Investors are also watching the Rs 256 crore cash the company received from selling two brands to Wipro Enterprises. Any bonus would need further approvals, so it will not arrive quickly.<\/p>\n<\/p><\/div>\n<p>TTK Healthcare share price jumped as much as 20% on Tuesday 17 November 2026, touching Rs 1,110.90, and was trading at Rs 1,054.95 on the BSE at 10:56 AM, up 14.44% from Rs 921.80. The trigger was a filing dated 16 November that the board will meet on 20 November to consider a preference share bonus.<\/p>\n<p>This article explains what the filing says and what it leaves out, how a preference share bonus differs from a regular bonus, the brand sale cash, the valuation and momentum readings, the second quarter profit and the risks. We keep facts, our own working and guesses clearly apart.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=ttk-healthcare-bonus-preference-shares\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Price_Action_at_10_56_AM_on_17_November\" title=\"Price Action at 10:56 AM on 17 November\">Price Action at 10:56 AM on 17 November<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#What_the_Filing_Says_and_What_It_Leaves_Out\" title=\"What the Filing Says and What It Leaves Out\">What the Filing Says and What It Leaves Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#How_a_Preference_Share_Bonus_Differs_From_a_Regular_Bonus\" title=\"How a Preference Share Bonus Differs From a Regular Bonus\">How a Preference Share Bonus Differs From a Regular Bonus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#What_the_TTK_Healthcare_Share_Price_Says_About_Valuation_and_Momentum\" title=\"What the TTK Healthcare Share Price Says About Valuation and Momentum\">What the TTK Healthcare Share Price Says About Valuation and Momentum<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#The_Rs_256_Crore_Brand_Sale_and_the_Cash_on_the_Books\" title=\"The Rs 256 Crore Brand Sale and the Cash on the Books\">The Rs 256 Crore Brand Sale and the Cash on the Books<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Second_Quarter_Profit_and_Why_It_Needs_Context\" title=\"Second Quarter Profit and Why It Needs Context\">Second Quarter Profit and Why It Needs Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Risks_and_What_to_Watch_Next\" title=\"Risks and What to Watch Next\">Risks and What to Watch Next<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Why_did_TTK_Healthcare_shares_jump_on_17_November_2026\" title=\"Why did TTK Healthcare shares jump on 17 November 2026?\">Why did TTK Healthcare shares jump on 17 November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#What_are_bonus_non-convertible_redeemable_preference_shares\" title=\"What are bonus non-convertible redeemable preference shares?\">What are bonus non-convertible redeemable preference shares?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#When_will_the_bonus_be_issued\" title=\"When will the bonus be issued?\">When will the bonus be issued?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Is_TTK_Healthcare_really_trading_at_a_price_to_earnings_of_47\" title=\"Is TTK Healthcare really trading at a price to earnings of 4.7?\">Is TTK Healthcare really trading at a price to earnings of 4.7?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#How_much_did_TTK_Healthcare_get_from_selling_its_brands\" title=\"How much did TTK Healthcare get from selling its brands?\">How much did TTK Healthcare get from selling its brands?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#What_happened_in_the_second_quarter_results\" title=\"What happened in the second quarter results?\">What happened in the second quarter results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/ttk-healthcare-share-price-jumps-20-percent-bonus-preference-shares-board-20-november-2026\/#Should_I_buy_the_stock_before_the_board_meeting\" title=\"Should I buy the stock before the board meeting?\">Should I buy the stock before the board meeting?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Price_Action_at_10_56_AM_on_17_November\"><\/span><strong>Price Action at 10:56 AM on 17 November<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Measure<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Figure at 10:56 AM<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/ttkhltcare\/ttk-healthcare-ltd-share-price-today\">TTK Healthcare (NSE: TTKHLTCARE)<\/a><\/td>\n<td>Rs 1,052.55 on NSE, up 13.70%<\/td>\n<\/tr>\n<tr>\n<td>BSE price<\/td>\n<td>Rs 1,054.95, up 14.44%<\/td>\n<\/tr>\n<tr>\n<td>Previous close on NSE<\/td>\n<td>Rs 925.75<\/td>\n<\/tr>\n<tr>\n<td>Open and day range<\/td>\n<td>Open Rs 1,067.65, high Rs 1,110.90, low Rs 1,025.00<\/td>\n<\/tr>\n<tr>\n<td>Peak gain from previous close<\/td>\n<td>About 20.0% (our arithmetic)<\/td>\n<\/tr>\n<tr>\n<td>NSE volume so far<\/td>\n<td>About 3.95 lakh shares<\/td>\n<\/tr>\n<tr>\n<td>52-week range<\/td>\n<td>Rs 735.00 to Rs 1,247.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>An early report put the volume at about 1.81 lakh shares by 9:10 AM, roughly 8.4 times the average of 21,420 shares. The volume has since more than doubled, which is about 18.5 times that average (our arithmetic). The next filing or data release could change how TTKHLTCARE is read.<\/p>\n<p>The stock gave back part of its opening spike, so the 20% headline is the intraday peak, not the current gain. Check the live quote before relying on any number. Many investors revisit TTK Healthcare bonus issue after the closing bell once final volumes are known.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Filing_Says_and_What_It_Leaves_Out\"><\/span><strong>What the Filing Says and What It Leaves Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Item<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Filing date<\/td>\n<td>16 November 2026, under Regulation 29 of the SEBI listing rules<\/td>\n<\/tr>\n<tr>\n<td>Board meeting<\/td>\n<td>Friday 20 November 2026<\/td>\n<\/tr>\n<tr>\n<td>Item on the agenda<\/td>\n<td>Scheme of Arrangement between the company and its equity shareholders<\/td>\n<\/tr>\n<tr>\n<td>Legal route<\/td>\n<td>Section 230 of the Companies Act, 2013<\/td>\n<\/tr>\n<tr>\n<td>What is proposed<\/td>\n<td>Bonus issue of non-convertible redeemable preference shares<\/td>\n<\/tr>\n<tr>\n<td>Not disclosed<\/td>\n<td>Ratio, number and face value, tenure, redemption terms, any coupon, rationale and record date<\/td>\n<\/tr>\n<tr>\n<td>Trading window<\/td>\n<td>Closed for designated persons from 16 to 22 November<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A report notes that a scheme of this kind generally needs more approvals, such as from shareholders and the National Company Law Tribunal, before any bonus is issued. That means the actual issue would come well after 20 November. A calm review of TTK Healthcare bonus issue usually beats a rushed reaction to one headline.<\/p>\n<p>Until the board meets, nobody outside the company knows the terms. The 20 November meeting only considers the scheme, and the board may approve it, change it or defer it. For TTK Healthcare stock, confirm each figure against the exchange filing before relying on it. For TTK Healthcare stock, confirm each figure against the exchange filing before relying on it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_a_Preference_Share_Bonus_Differs_From_a_Regular_Bonus\"><\/span><strong>How a Preference Share Bonus Differs From a Regular Bonus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Feature<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Regular bonus shares<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Bonus preference shares (as proposed)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>What you receive<\/td>\n<td>Extra equity shares<\/td>\n<td>A separate redeemable preference security<\/td>\n<\/tr>\n<tr>\n<td>Effect on equity share count<\/td>\n<td>Rises, and the price adjusts on the ex-date<\/td>\n<td>Not stated in the filing<\/td>\n<\/tr>\n<tr>\n<td>Ownership and voting<\/td>\n<td>Same as existing equity<\/td>\n<td>Depends on terms not yet disclosed<\/td>\n<\/tr>\n<tr>\n<td>Payout<\/td>\n<td>Only through later dividends<\/td>\n<td>Redemption and any coupon depend on the terms<\/td>\n<\/tr>\n<tr>\n<td>Approvals<\/td>\n<td>Usually a board and shareholder resolution<\/td>\n<td>A court-supervised scheme under Section 230 here<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Non-convertible means the preference shares cannot be turned into equity, and redeemable means the company can repay them on a set basis later. The terms of this scheme have not been published. No single data point settles the question on TTK Healthcare bonus issue. No single data point settles the question on TTK Healthcare bonus issue.<\/p>\n<p>The company has not said why it wants this structure. Some investors read it as a way to return surplus cash, but that is a guess, not a statement from the filing. Past patterns behind TTKHLTCARE do not guarantee a repeat. Past patterns behind TTKHLTCARE do not guarantee a repeat.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare healthcare stocks on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_TTK_Healthcare_Share_Price_Says_About_Valuation_and_Momentum\"><\/span><strong>What the TTK Healthcare Share Price Says About Valuation and Momentum<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Indicator<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Reading<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Context<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Price to earnings<\/td>\n<td>4.71 at the previous close<\/td>\n<td>Industry average 24.86<\/td>\n<\/tr>\n<tr>\n<td>Price to book<\/td>\n<td>0.97 at the previous close<\/td>\n<td>About 1.11 at the live price (our arithmetic)<\/td>\n<\/tr>\n<tr>\n<td>Book value per share<\/td>\n<td>Rs 949.82<\/td>\n<td>Trailing earnings per share Rs 195.71<\/td>\n<\/tr>\n<tr>\n<td>Return on equity<\/td>\n<td>5.39%<\/td>\n<td>Debt to equity 0.02<\/td>\n<\/tr>\n<tr>\n<td>Dividend yield<\/td>\n<td>1.08%<\/td>\n<td>Another screen shows 0.96%<\/td>\n<\/tr>\n<tr>\n<td>14-day RSI<\/td>\n<td>53.74<\/td>\n<td>Neutral zone<\/td>\n<\/tr>\n<tr>\n<td>50-day simple average<\/td>\n<td>Rs 1,015.14<\/td>\n<td>Price is about 3.7% above<\/td>\n<\/tr>\n<tr>\n<td>20-day exponential average<\/td>\n<td>Rs 964.80<\/td>\n<td>Price is about 9.1% above<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The price to earnings of 4.71 looks very low, but trailing earnings per share of Rs 195.71 is inflated by a one-off gain from the brand sale, explained below. On operating earnings the stock is not nearly as inexpensive as that ratio suggests (our reading). Broader market direction also influences TTK Healthcare shares on any given day.<\/p>\n<p>Market value is about Rs 1,491 crore at the live price on a share count of about 1.41 crore (our arithmetic), against Rs 1,303 crore in the data feed at the previous close. On TTK Healthcare bonus issue, a fair view compares today&#8217;s numbers with the previous quarter. On TTK Healthcare bonus issue, a fair view compares today&#8217;s numbers with the previous quarter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_Rs_256_Crore_Brand_Sale_and_the_Cash_on_the_Books\"><\/span><strong>The Rs 256 Crore Brand Sale and the Cash on the Books<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Item<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Buyer<\/td>\n<td>Wipro Enterprises, for the EVA and Good Home brands<\/td>\n<\/tr>\n<tr>\n<td>Consideration<\/td>\n<td>Rs 256 crore plus GST, received in cash<\/td>\n<\/tr>\n<tr>\n<td>Agreements signed<\/td>\n<td>23 July 2026, completion reported in early September<\/td>\n<\/tr>\n<tr>\n<td>Revenue of the two brands in FY26<\/td>\n<td>Rs 148 crore, about 17% of company turnover<\/td>\n<\/tr>\n<tr>\n<td>Net book value of assets sold<\/td>\n<td>Rs 0.70 crore (as of 30 June 2026)<\/td>\n<\/tr>\n<tr>\n<td>Cash as a share of market value<\/td>\n<td>About 17% at the live price (our arithmetic, before tax)<\/td>\n<\/tr>\n<tr>\n<td>Cash per share<\/td>\n<td>About Rs 181 (our arithmetic, before tax and GST)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The price works out to about 1.7 times the brands&#8217; annual revenue. The company has not said how it will use the cash, and the filing for the board meeting does not link the cash to the scheme. Comparing TTK Healthcare shares with peers gives a better sense of context.<\/p>\n<p>Taxes on the sale will reduce what is left for shareholders, so treat the per-share figure as a ceiling. Human pharma was sold earlier in May 2022, and the remaining business covers consumer brands, medical devices, animal health and foods. With TTKHLTCARE, position size matters more than precision. With TTKHLTCARE, position size matters more than precision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Second_Quarter_Profit_and_Why_It_Needs_Context\"><\/span><strong>Second Quarter Profit and Why It Needs Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Measure<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Q2 FY27<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Comparison<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Standalone revenue<\/td>\n<td>Rs 233.38 crore<\/td>\n<td>Up 14.64% from Rs 203.57 crore<\/td>\n<\/tr>\n<tr>\n<td>Operating profit<\/td>\n<td>Rs 3.75 crore<\/td>\n<td>EBITDA margin about 1.6%, down from 2.62%<\/td>\n<\/tr>\n<tr>\n<td>Net profit<\/td>\n<td>Rs 222.97 crore<\/td>\n<td>Up about 994% from Rs 20.39 crore<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 net profit<\/td>\n<td>Rs 21.30 crore<\/td>\n<td>Up 63.85%, revenue Rs 260 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Operating profit was only Rs 3.75 crore, while net profit was Rs 222.97 crore. The gap very likely comes from the gain on the brand sale, though we have not seen the exceptional item line itself, so confirm it in the filing. Reading TTKHLTCARE alongside the sector trend avoids a narrow conclusion.<\/p>\n<p>Without that gain, the quarter shows modest revenue growth and thinner margins. That is why the headline profit jump is a poor guide to the business&#8217;s regular earning power. Volume is a useful cross-check for TTK Healthcare shares. Volume is a useful cross-check for TTK Healthcare shares.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_and_What_to_Watch_Next\"><\/span><strong>Risks and What to Watch Next<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Risk<\/th>\n<th style=\"background:#1F4E79;color:#FFFFFF;text-align:left;\">Why it matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Unknown terms<\/td>\n<td>The ratio, tenure and payout are not public until the board decides<\/td>\n<\/tr>\n<tr>\n<td>Long approval path<\/td>\n<td>Shareholder and tribunal approvals can take months<\/td>\n<\/tr>\n<tr>\n<td>Board outcome<\/td>\n<td>The board can approve, change or defer the scheme<\/td>\n<\/tr>\n<tr>\n<td>One-off earnings<\/td>\n<td>A low price to earnings rests on a sale gain, not repeat profit<\/td>\n<\/tr>\n<tr>\n<td>Thin liquidity<\/td>\n<td>The average volume is only about 21,000 shares, so prices can swing sharply<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Watch the outcome of the 20 November meeting, the exact terms in the exchange filing and any record date. A trading window closure until 22 November also limits purchases by company insiders. Set risk limits before acting on any view of TTK Healthcare stock.<\/p>\n<p>Univest does not give buy or sell calls, and this article is general information. Size any position to your own risk limits. Updates related to TTK Healthcare stock often arrive after market hours, so check again at the next open. Updates related to TTK Healthcare stock often arrive after market hours, so check again at the next open.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track this stock and set price alerts.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock jumped on a short filing that names a preference share bonus but gives no terms. The board meets on 20 November, and any issue would need further approvals after that. When reading TTK Healthcare shares, intraday moves can reverse before the close, so timing matters. When reading TTK Healthcare shares, intraday moves can reverse before the close, so timing matters.<\/p>\n<p>A low price to earnings and Rs 256 crore of sale cash support interest, yet the profit jump comes from a one-off gain and operating margins are thin. Wait for the actual terms before forming a view. Note the date and time of any price quoted in TTK Healthcare stock.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_TTK_Healthcare_shares_jump_on_17_November_2026\"><\/span><strong>Why did TTK Healthcare shares jump on 17 November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company told the exchanges on 16 November that its board will meet on 20 November to consider a scheme to issue non-convertible redeemable preference shares as a bonus to equity shareholders. The stock rose as much as 20% to Rs 1,110.90 on the news.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_bonus_non-convertible_redeemable_preference_shares\"><\/span><strong>What are bonus non-convertible redeemable preference shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> They are preference shares given free to existing equity holders. They cannot be converted into equity, and the company can redeem them later on set terms. The ratio, tenure and any coupon for this scheme have not been disclosed yet.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_will_the_bonus_be_issued\"><\/span><strong>When will the bonus be issued?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Not soon. The board only considers the scheme on 20 November 2026. A scheme under Section 230 generally needs shareholder and National Company Law Tribunal approvals, so any issue and record date would follow those steps and could take months.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_TTK_Healthcare_really_trading_at_a_price_to_earnings_of_47\"><\/span><strong>Is TTK Healthcare really trading at a price to earnings of 4.7?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The data feed shows 4.71 at the previous close against an industry figure of 24.86. However, trailing earnings are inflated by the gain on selling the EVA and Good Home brands, so the ratio flatters the company. Regular operating profit is much lower.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_TTK_Healthcare_get_from_selling_its_brands\"><\/span><strong>How much did TTK Healthcare get from selling its brands?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It received Rs 256 crore plus GST in cash from Wipro Enterprises for the EVA and Good Home brands. The brands earned Rs 148 crore of revenue in FY26, about 17% of turnover. The company has not said how it will use the cash.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_happened_in_the_second_quarter_results\"><\/span><strong>What happened in the second quarter results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Standalone revenue was Rs 233.38 crore, up 14.64%, and net profit was Rs 222.97 crore against Rs 20.39 crore a year earlier. Operating profit was just Rs 3.75 crore, so the profit jump very likely reflects the brand sale gain.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_buy_the_stock_before_the_board_meeting\"><\/span><strong>Should I buy the stock before the board meeting?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Univest does not give buy or sell calls. The terms are unknown, the approval path is long and trading volume is thin, so prices can reverse quickly. Review the filing after 20 November and set your own risk limits first.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did TTK Healthcare shares jump on 17 November 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The company told the exchanges on 16 November that its board will meet on 20 November to consider a scheme to issue non-convertible redeemable preference shares as a bonus to equity shareholders. The stock rose as much as 20% to Rs 1,110.90 on the news.\"}},{\"@type\":\"Question\",\"name\":\"What are bonus non-convertible redeemable preference shares?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"They are preference shares given free to existing equity holders. They cannot be converted into equity, and the company can redeem them later on set terms. The ratio, tenure and any coupon for this scheme have not been disclosed yet.\"}},{\"@type\":\"Question\",\"name\":\"When will the bonus be issued?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Not soon. The board only considers the scheme on 20 November 2026. A scheme under Section 230 generally needs shareholder and National Company Law Tribunal approvals, so any issue and record date would follow those steps and could take months.\"}},{\"@type\":\"Question\",\"name\":\"Is TTK Healthcare really trading at a price to earnings of 4.7?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The data feed shows 4.71 at the previous close against an industry figure of 24.86. However, trailing earnings are inflated by the gain on selling the EVA and Good Home brands, so the ratio flatters the company. Regular operating profit is much lower.\"}},{\"@type\":\"Question\",\"name\":\"How much did TTK Healthcare get from selling its brands?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It received Rs 256 crore plus GST in cash from Wipro Enterprises for the EVA and Good Home brands. The brands earned Rs 148 crore of revenue in FY26, about 17% of turnover. The company has not said how it will use the cash.\"}},{\"@type\":\"Question\",\"name\":\"What happened in the second quarter results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Standalone revenue was Rs 233.38 crore, up 14.64%, and net profit was Rs 222.97 crore against Rs 20.39 crore a year earlier. Operating profit was just Rs 3.75 crore, so the profit jump very likely reflects the brand sale gain.\"}},{\"@type\":\"Question\",\"name\":\"Should I buy the stock before the board meeting?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Univest does not give buy or sell calls. The terms are unknown, the approval path is long and trading volume is thin, so prices can reverse quickly. Review the filing after 20 November and set your own risk limits first.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>TTK Healthcare share price jumped up to 20% as the board meets on 20 November on a preference share bonus. See facts, valuation and risks.<\/p>\n","protected":false},"author":35,"featured_media":349782,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[24680,24681,24679,24678,24682],"class_list":["post-349783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-preference-shares","tag-ttk-healthcare-board-meeting","tag-ttk-healthcare-bonus-issue","tag-ttk-healthcare-share-price","tag-wipro-enterprises"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["349782"],"rank_math_title":["TTK Healthcare Bonus Preference Shares: Stock Jumps Up to 20%"],"rank_math_description":["TTK Healthcare share price jumped up to 20% on 17 November 2026 as the board meets on 20 November on a preference share bonus. See the facts, valuation and risks."],"rank_math_focus_keyword":["TTK Healthcare share price | Density Target: 1.2-1.5%"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/ttk-healthcare-share-price-surges-up-to-20-on-17-november-2026-as-the-board.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/349783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=349783"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/349783\/revisions"}],"predecessor-version":[{"id":349784,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/349783\/revisions\/349784"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/349782"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=349783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=349783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=349783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}